Long-term safety of a new schizophrenia medication
Part of Mental health clinical trials.
This study tests a new medication called HS-10380 for schizophrenia over a longer period to see if it is safe. It may help people who are looking for a treatment that can be taken long-term.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have a diagnosis of schizophrenia.
- You are willing to stop taking your current antipsychotic medications before the study starts.
- You are generally healthy and do not have other major psychiatric conditions.
- You do not have a history of drug or alcohol abuse in the past year.
- You are not pregnant, breastfeeding, or at risk of pregnancy during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests the safety of a new medication called LY03020. It is for healthy volunteers and for people with stable schizophrenia. The study aims to see how well the body handles the drug and what side effects might occur.
This trial tests whether a new version of an extended-release injection is as effective as the original in people with schizophrenia. The study helps ensure patients have access to a reliable treatment option.
This study is testing how safe and tolerable an investigational medication is over the long term (52 weeks) when added to your current antipsychotic treatment. It's for people with schizophrenia whose symptoms are stable, and it aims to see if the new medication can help without causing serious side effects.
This trial tests a new medication (HHK101) for people with stable schizophrenia. It aims to see if the drug is safe and how it works in the body. Participants must be on a steady dose of their current antipsychotic.
This trial tests a new medication called LB-102 for people with acute (sudden worsening of) schizophrenia. It aims to see if the drug helps reduce symptoms like hallucinations or disorganized thinking.
This trial tests a new medication called SEP-363856 over a long period for people with schizophrenia who are currently stable. It looks at how well the drug works and its safety over time.
Hear when a new SCHIZOPHRENIA 1 (Disorder) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.